Earnings tomorrow before the bell and CC at 11AM. A while ago I posed a few key question I would like answered on the Yahoo! thread, one of the few such that doesn't have hordes of utterly clueless longs and shorts taunting each other and making outrageous claims. Only a select few of those. Anyhow, the link:
finance.messages.yahoo.com
Q3 has been partly answered: Ovarian, big surprise. But exactly what form it will take and what the timeline will be has not. Further, CIPH has stated that they would choose a couple, and I don't recall hearing about the second one yet.
On a tough day ahead of earnings, CIPH dipped briefly below $7 a while ago. Some feel pushouts from last quarter will make it into this quarter. Maybe, but I've found that pushouts are a red flag, especially in the context of flat sales, reproducibility issues, and a new system coming. I think sales will remain slow for a while, given the next generation system to be launched later this year. However, those who like standard MS platforms might like the interface, and I'd be curious to see the sales trends of those. Chips sales should hold up, maybe ramp some, but not systems.
My personal feeling is that the next few quarters are going to be flat to down, and the stock price down. I'm guessing under $6 by late summer, at which point I would seriously consider getting back in, with the new system ready to go, and clinical diagnostics closer to market, too. Getting in cheap in front of those drivers seems like the strategy to me. I welcome thoughts of others, be they dissenting or not.
Cheers, Tuck |
